0001415889-23-016253.txt : 20231211 0001415889-23-016253.hdr.sgml : 20231211 20231211180025 ACCESSION NUMBER: 0001415889-23-016253 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231207 FILED AS OF DATE: 20231211 DATE AS OF CHANGE: 20231211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GLENN JOHN CENTRAL INDEX KEY: 0001253497 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36534 FILM NUMBER: 231479515 MAIL ADDRESS: STREET 1: 7900 HOPYARD ROAD STREET 2: APT 210 CITY: PLEASANTON STATE: CA ZIP: 94577 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IRADIMED CORP CENTRAL INDEX KEY: 0001325618 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 731408526 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1025 WILLA SPRINGS DR. CITY: WINTER SPRINGS STATE: FL ZIP: 32708 BUSINESS PHONE: 4076778022 MAIL ADDRESS: STREET 1: 1025 WILLA SPRINGS DR. CITY: WINTER SPRINGS STATE: FL ZIP: 32708 4 1 form4-12112023_061212.xml X0508 4 2023-12-07 0001325618 IRADIMED CORP IRMD 0001253497 GLENN JOHN C/O IRADIMED CORPORATION 1025 WILLA SPRINGS DR. WINTER SPRINGS FL 32708 false true false false CHIEF FINANCIAL OFFICER 0 Restricted Stock Units 2023-12-07 4 A 0 7180 0 A Common Stock 7180 35072 D Performance-based Restricted Stock Units 2023-12-07 4 A 0 7180 0 A Common Stock 7180 17684 D Restricted stock units convert into common stock on a one-for-one basis. The reporting person received restricted stock units ("RSUs") under Iradimed Corporation's 2014 Equity Incentive Plan. The RSUs vest in full on the third anniversary of the grant date, December 7, 2026. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The reporting person received performance-based restricted stock units ("PRSUs") under Iradimed Corporation's 2014 Equity Incentive Plan. Vesting of these PRSUs depends on the reporting person's achievement of specified relative ranking of total shareholder return over a three-year period from December 8, 2023 through December 7, 2026. If the relative measure at December 7, 2026 and for the three-year period then ended is: (i) less than or equal to 80% of the peer group, no vesting would occur, (ii) between 80% and 100% of the peer group, the number of shares vesting would be pro-rata against the nominal granted shares, (iii) equal to 100% of the peer group, the number of shares vesting would be the nominal granted shares, (iv) between 100%and 120% of the peer group, the number of shares vesting would be pro-rata against an additional tranche of the nominal granted shares plus the nominal granted shares, and (v) if 120% or greater of the peer group, the number of shares vesting would be double the nominal granted shares. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of PRSUs that have vested. /s/ John Glenn 2023-12-11